233 related articles for article (PubMed ID: 19221060)
1. Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT.
Luo W; Numata K; Morimoto M; Kondo M; Takebayashi S; Okada M; Morita S; Tanaka K
Radiology; 2009 Apr; 251(1):287-95. PubMed ID: 19221060
[TBL] [Abstract][Full Text] [Related]
2. Focal Liver Lesions: Real-time 3-Dimensional Contrast-Enhanced Ultrasonography Compared With 2-Dimensional Contrast-Enhanced Ultrasonography and Magnetic Resonance Imaging.
Lee JC; Yan K; Lee SK; Yang W; Chen MH
J Ultrasound Med; 2017 Oct; 36(10):2015-2026. PubMed ID: 28646628
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods.
Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Tanaka K
AJR Am J Roentgenol; 2009 Jan; 192(1):165-73. PubMed ID: 19098197
[TBL] [Abstract][Full Text] [Related]
4. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of focal liver lesions using three-dimensional ultrasonography: retrospective and prospective studies.
Luo W; Numata K; Morimoto M; Nozaki A; Ueda M; Kondo M; Morita S; Tanaka K
World J Gastroenterol; 2010 May; 16(17):2109-19. PubMed ID: 20440851
[TBL] [Abstract][Full Text] [Related]
6. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images.
Burns PN; Wilson SR
Radiology; 2007 Jan; 242(1):162-74. PubMed ID: 17090710
[TBL] [Abstract][Full Text] [Related]
7. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K
Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941
[TBL] [Abstract][Full Text] [Related]
8. Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index.
Luo W; Numata K; Kondo M; Morimoto M; Sugimori K; Hirasawa K; Nozaki A; Zhou X; Tanaka K
J Ultrasound Med; 2009 Apr; 28(4):439-48. PubMed ID: 19321671
[TBL] [Abstract][Full Text] [Related]
9. Hepatic perfusion disorder associated with focal liver lesions: contrast-enhanced US patterns--correlation study with contrast-enhanced CT.
Zhou X; Luo Y; Peng YL; Cai W; Lu Q; Lin L; Sha XX; Li YZ; Zhu M
Radiology; 2011 Jul; 260(1):274-81. PubMed ID: 21467250
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.
Numata K; Fukuda H; Ohto M; Itou R; Nozaki A; Kondou M; Morimoto M; Karasawa E; Tanaka K
Eur J Radiol; 2010 Aug; 75(2):e67-75. PubMed ID: 20015603
[TBL] [Abstract][Full Text] [Related]
11. 3D analysis is superior to 2D analysis for contrast-enhanced ultrasound in revealing vascularity in focal liver lesions - A retrospective analysis of 83 cases.
Dong FJ; Xu JF; Du D; Jiao Y; Zhang L; Li M; Liu HY; Xiong Y; Luo H
Ultrasonics; 2016 Aug; 70():221-6. PubMed ID: 27235776
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial.
Moriyasu F; Itoh K
AJR Am J Roentgenol; 2009 Jul; 193(1):86-95. PubMed ID: 19542399
[TBL] [Abstract][Full Text] [Related]
14. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
[TBL] [Abstract][Full Text] [Related]
16. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
17. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
Shagdarsuren B; Tamai H; Shingaki N; Mori Y; Maeshima S; Nuta J; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
J Ultrasound Med; 2016 Jul; 35(7):1383-91. PubMed ID: 27208196
[TBL] [Abstract][Full Text] [Related]
18. Automatic detection and classification of hypodense hepatic lesions on contrast-enhanced venous-phase CT.
Bilello M; Gokturk SB; Desser T; Napel S; Jeffrey RB; Beaulieu CF
Med Phys; 2004 Sep; 31(9):2584-93. PubMed ID: 15487741
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of focal liver lesions: usefulness of parametric imaging with contrast-enhanced US.
Anaye A; Perrenoud G; Rognin N; Arditi M; Mercier L; Frinking P; Ruffieux C; Peetrons P; Meuli R; Meuwly JY
Radiology; 2011 Oct; 261(1):300-10. PubMed ID: 21746815
[TBL] [Abstract][Full Text] [Related]
20. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK
Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
